Biology of adeno-associated viral vectors in the central nervous system

Frontiers in Molecular Neuroscience

Volumn 7, Issue , 2014, Pages

  Murlidharan, Giridhar ^a   Samulski, Richard J ^a   Asokan, Aravind ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Adeno associated virus (AAV); Gene therapy; Neurodegenerative diseases; Neurological disorders; Viral vectors

Indexed keywords

AMINO ACID DECARBOXYLASE; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANTIGEN PRESENTATION; ANTIGENICITY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; DEGENERATIVE DISEASE; GENE EXPRESSION; GENE THERAPY; GENETIC DISORDER; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; INTRACELLULAR TRANSPORT; MOLECULAR BIOLOGY; NERVE FIBER TRANSPORT; NEUROLOGIC DISEASE; NONHUMAN; REVIEW; SEROTYPE; SIGNAL TRANSDUCTION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL TROPISM; VIRUS CAPSID;

EID: 84907299494     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00076     Document Type: Review

References (114)

1. Abbott, N. J. (2004). Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem. Int. 45, 545-552. doi: 10.1016/j.neuint.2003.11.006
2. Agbandje-McKenna, M., and Kleinschmidt, J. (2011). AAV capsid structure and cell interactions. Methods Mol. Biol. 807, 47-92. doi: 10.1007/978-1-61779-370-7_3
3. Ahmed, S. S., Li, H., Cao, C., Sikoglu, E. M., Denninger, A. R., Su, Q., et al. (2013). A single intravenous rAAV injection as late as P.0 achieves efficacious and sustained CNS gene therapy in canavan mice. Mol. Ther. 21, 2136-2147. doi: 10.1038/mt.2013.138
4. Alvarez-Buylla, A., and Lim, D. A. (2004). For the long run: maintaining germinal niches in the adult brain. Neuron 41, 683-686. doi: 10.1016/S0896-6273(04)00111-4
5. Arnett, A. L., Beutler, L. R., Quintana, A., Allen, J., Finn, E., P.lmiter, R. D., et al. (2013). Heparin-binding correlates with increased efficiency of AAV1and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction. Gene Ther. 20, 497-503. doi: 10.1038/gt.2012.60
6. Asokan, A., Schaffer, D. V., and Jude Samulski, R. (2012). The AAV vector toolkit: poised at the clinical crossroads. Mol. Ther. 20, 699-708. doi: 10.1038/mt.2011.287
7. Bartlett, J. S., Samulski, R. J., and McCown, T. J. (1998). Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum. Gene Ther. 9, 1181-1186. doi: 10.1089/hum.1998.9.8-1181
8. Beier, K. T., Saunders, A., Oldenburg, I. A., Miyamichi, K., Akhtar, N., Luo, L., et al. (2011). Anterograde or retrograde transsynaptic labeling of CNS neurons with vesicular stomatitis virus vectors. P.oc. Natl. Acad. Sci. U.S.A. 108, 15414-15419. doi: 10.1073/pnas.1110854108
9. Bell, C. L., Vandenberghe, L. H., Bell, P., Limberis, M. P., Gao, G. P., Van Vliet, K., et al. (2011). The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J. Clin. Invest. 121, 2427-2435. doi: 10.1172/JCI57367
10. Benkhelifa-Ziyyat, S., Besse, A., Roda, M., Duque, S., Astord, S., Carcenac, R., et al. (2013). Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice. Mol. Ther. 21, 282-290. doi: 10.1038/mt.2012.261
11. Benraiss, A., Bruel-Jungerman, E., Lu, G., Economides, A. N., Davidson, B., and Goldman, S. A. (2012). Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF. Gene Ther. 19, 483-493. doi: 10.1038/gt.2011.114
12. Bevan, A. K., Duque, S., Foust, K. D., Morales, P. R., Braun, L., Schmelzer, L., et al. (2011). Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol. Ther. 19, 1971-1980. doi: 10.1038/mt.2011.157
13. Bockstael, O., Melas, C., P.thoud, C., Levivier, M., McCarty, D., Samulski, R. J., et al. (2012). Rapid transgene expression in multiple precursor cell types of adult rat subventricular zone mediated by adeno-associated type 1 vectors. Hum. Gene Ther. 23, 742-753. doi: 10.1089/hum.2011.216
14. Bokhoven, M., Stephen, S. L., Knight, S., Gevers, E. F., Robinson, I. C., Takeuchi, Y., et al. (2009). Insertional gene activation by lentiviral and gammaretroviral vectors. J. Virol. 83, 283-294. doi: 10.1128/JVI.01865-08
15. Boustany, R. M. (2013). Lysosomal storage diseases the horizon expands. Nat. Rev. Neurol. 9, 583-598. doi: 10.1038/nrneurol.2013.163
16. Bowles, D. E., Rabinowitz, J. E., and Samulski, R. J. (2006). "The genus dependovirus," in P.rvoviruses eds J. R. Kerr, S. F. Cotmore, M. E. Bloom, R. M. Linden, and C. R. P.rrish (New York: Edward Arnold Ltd.), 15-24.
17. Broekman, M. L., Comer, L. A., Hyman, B. T., and Sena-Esteves, M. (2006). Adenoassociated virus vectors serotyped with AAV8 capsid are more efficient than AAV1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 138, 501-510. doi: 10.1016/j.neuroscience.2005.11.057
18. Burger, C., Gorbatyuk, O. S., Velardo, M. J., P.den, C. S., Williams, P., Zolotukhin, S., et al. (2004). Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10, 302-317. doi: 10.1016/j.ymthe.2004.05.024
19. Cabrera-Salazar, M. A., Bercury, S. D., Ziegler, R. J., Marshall, J., Hodges, B. L., Chuang, W. L., et al. (2010). Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic gaucher disease. Exp. Neurol. 225, 436-444. doi: 10.1016/j.expneurol.2010.07.023
20. Castle, M. J., Gershenson, Z. T., Giles, A. R., Holzbaur, E. L., and Wolfe, J. H. (2014a). Adeno-associated virus serotypes 1, 8, and 9 share conserved mechanisms for anterograde and retrograde axonal transport. Hum. Gene Ther. 25, 705-720. doi: 10.1089/hum.2013.189
21. Castle, M. J., P.rlson, E., Holzbaur, E. L., and Wolfe, J. H. (2014b). Long-distance axonal transport of AAV9 is driven by dynein and kinesin-2 and is trafficked in a highly motile Rab7-positive compartment. Mol. Ther. 22, 554-566. doi: 10.1038/mt.2013.237
22. Cearley, C. N., Vandenberghe, L. H., P.rente, M. K., Carnish, E. R., Wilson, J. M., and Wolfe, J. H. (2008). Expanded repertoire of AAV vector serotypes mediate unique patterns of transduction in mouse brain. Mol. Ther. 16, 1710-1718. doi: 10.1038/mt.2008.166
23. Cearley, C. N., and Wolfe, J. H. (2006). Transduction characteristics of adenoassociated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol. Ther. 13, 528-537. doi: 10.1016/j.ymthe.2005.11.015
24. Cearley, C. N., and Wolfe, J. H. (2007). A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease. J. Neurosci. 27, 9928-9940. doi: 10.1523/JNEUROSCI.2185-07.2007
25. Chakrabarty, P., Rosario, A., Cruz, P., Siemienski, Z., Ceballos-Diaz, C., Crosby, K., et al. (2013). Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. P.oS ONE 8:e67680. doi: 10.1371/journal.pone.0067680
26. Chamberlin, N. L., Du, B., de Lacalle, S., and Saper, C. B. (1998). Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS. Brain Res. 793, 169-175. doi: 10.1016/S0006-8993(98)00169-3
27. Chen, Y. H., Claflin, K., Geoghegan, J. C., and Davidson, B. L. (2012). Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage disease. Mol. Ther. 20, 1393-1399. doi: 10.1038/mt.2012.100
28. Ciesielska, A., Hadaczek, P., Mittermeyer, G., Zhou, S., Wright, J. F., Bankiewicz, K. S., et al. (2013). Cerebral infusion of AAV9 vector-encoding non-self proteins can elicit cell-mediated immune responses. Mol. Ther. 21, 158-166. doi: 10.1038/mt.2012.167
29. Ciesielska, A., Mittermeyer, G., Hadaczek, P., Kells, A. P., Forsayeth, J., and Bankiewicz, K. S. (2011). Anterograde axonal transport of AAV2-GDNF in rat basal ganglia. Mol. Ther. 19, 922-927. doi: 10.1038/mt.2010.248
30. Cserr, H. F., Harling-Berg, C. J., and Knopf, P. M. (1992). Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain P.thol. 2, 269-276. doi: 10.1111/j.1750-3639.1992.tb00703.x
31. Davidson, B. L., Stein, C. S., Heth, J. A., Martins, I., Kotin, R. M., Derksen, T. A., et al. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. P.oc. Natl. Acad. Sci. U.S.A. 97, 3428-3432. doi: 10.1073/pnas.97.7.3428
32. Dayton, R. D., Wang, D. B., and Klein, R. L. (2012). The advent of AAV9 expands applications for brain and spinal cord gene delivery. Expert Opin. Biol. Ther. 12, 757-766. doi: 10.1517/14712598.2012.681463
33. Dismuke, D. J., Tenenbaum, L., and Samulski, R. J. (2013). Biosafety of recombinant adeno-associated virus vectors. Curr. Gene Ther. 13, 434-452. doi: 10.2174/15665232113136660007
34. Duan, D., Sharma, P., Yang, J., Yue, Y., Dudus, L., Zhang, Y., et al. (1998). Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72, 8568-8577.
35. Federici, T., Taub, J. S., Baum, G. R., Gray, S. J., Grieger, J. C., Matthews, K. A., et al. (2012). Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther. 19, 852-859. doi: 10.1038/gt.2011.130
36. Foust, K. D., Nurre, E., Montgomery, C. L., Hernandez, A., Chan, C. M., and Kaspar, B. K. (2009). Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat. Biotechnol. 27, 59-65. doi: 10.1038/nbt.1515
37. Fu, H., Kang, L., Jennings, J. S., Moy, S. S., P.rez, A., Dirosario, J., et al. (2007). Significantly increased lifespan and improved behavioral performances by rAAV gene delivery in adult mucopolysaccharidosis IIIB mice. Gene Ther. 14, 1065-1077. doi: 10.1038/sj.gt.3302961
38. Fu, H., Muenzer, J., Samulski, R. J., Breese, G., Sifford, J., Zeng, X., et al. (2003). Selfcomplementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol. Ther. 8, 911-917. doi: 10.1016/j.ymthe.2003.08.021
39. Gao, G. P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., and Wilson, J. M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. P.oc. Natl. Acad. Sci. U.S.A. 99, 11854-11859. doi: 10.1073/pnas.182412299
40. Gao, G., Vandenberghe, L. H., Alvira, M. R., Lu, Y., Calcedo, R., Zhou, X., et al. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388. doi: 10.1128/JVI.78.12.6381-6388.2004
41. Glascock, J. J., Osman, E. Y., Wetz, M. J., Krogman, M. M., Shababi, M., and Lorson, C. L. (2012). Decreasing disease severity in symptomatic, smn(-/-);SMN2(+/+), spinal muscular atrophy mice following scAAV9-SMN delivery. Hum. Gene Ther. 23, 330-335. doi: 10.1089/hum.2011.166
42. Govindasamy, L., P.dron, E., McKenna, R., Muzyczka, N., Kaludov, N., Chiorini, J. A., et al. (2006). Structurally mapping the diverse phenotype of adenoassociated virus serotype 4. J. Virol. 80, 11556-11570. doi: 10.1128/JVI. 01536-06
43. Granstedt, A. E., Brunton, B. W., and Enquist, L. W. (2013). Imaging the transport dynamics of single alphaherpesvirus particles in intact peripheral nervous system explants from infected mice. MBio 4:e00358-e00313. doi: 10.1128/mBio.00358-13
44. Gray, S. J. (2013). Gene therapy and neurodevelopmental disorders. Neuropharmacology 68, 136-142. doi: 10.1016/j.neuropharm.2012.06.024
45. Gray, S. J., Blake, B. L., Criswell, H. E., Nicolson, S. C., Samulski, R. J., McCown, T. J., et al. (2010). Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB). Mol. Ther. 18, 570-578. doi: 10.1038/mt.2009.292
46. Gray, S. J., Matagne, V., Bachaboina, L., Yadav, S., Ojeda, S. R., and Samulski, R. J. (2011). P.eclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol. Ther. 19, 1058-1069. doi: 10.1038/mt.2011.72
47. Gray, S. J., Nagabhushan Kalburgi, S., McCown, T. J., and Jude Samulski, R. (2013). Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther. 20, 450-459. doi: 10.1038/gt.2012.101
48. Grieger, J. C., Choi, V. W., and Samulski, R. J. (2006). P.oduction and characterization of adeno-associated viral vectors. Nat. P.otoc. 1, 1412-1428. doi: 10.1038/nprot.2006.207
49. Hadaczek, P., Forsayeth, J., Mirek, H., Munson, K., Bringas, J., P.virotto, P., et al. (2009). Transduction of nonhuman primate brain with adeno-associated virus serotype 1: vector trafficking and immune response. Hum. Gene Ther. 20, 225-237. doi: 10.1089/hum.2008.151
50. Hadaczek, P., Yamashita, Y., Mirek, H., Tamas, L., Bohn, M. C., Noble, C., et al. (2006). The "perivascular pump" driven by arterial pulsation is a powerful mechanism for the distribution of therapeutic molecules within the brain. Mol. Ther. 14, 69-78. doi: 10.1016/j.ymthe.2006.02.018
51. Handa, A., Muramatsu, S., Qiu, J., Mizukami, H., and Brown, K. E. (2000). Adeno-associated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J. Gen. Virol. 81(P. 8), 2077-2084.
52. Hirai, T., Enomoto, M., Machida, A., Yamamoto, M., Kuwahara, H., Tajiri, M., et al. (2012). Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice. Hum. Gene Ther. Methods 23, 119-127. doi: 10.1089/hgtb.2012.035
53. Hollis, E. R. II, Kadoya, K., Hirsch, M., Samulski, R. J., and Tuszynski, M. H. (2008). Efficient retrograde neuronal transduction utilizing self-complementary AAV1. Mol. Ther. 16, 296-301. doi: 10.1038/sj.mt.6300367
54. Hsueh, Y. P., and Sheng, M. (1999). Regulated expression and subcellular localization of syndecan heparan sulfate proteoglycans and the syndecan-binding protein CASK/LIN-2 during rat brain development. J. Neurosci. 19, 7415-7425.
55. Hsueh, Y. P., Yang, F. C., Kharazia, V., Naisbitt, S., Cohen, A. R., Weinberg, R. J., et al. (1998). Direct interaction of CASK/LIN-2 and syndecan heparan sulfate proteoglycan and their overlapping distribution in neuronal synapses. J. Cell Biol. 142, 139-151. doi: 10.1083/jcb.142.1.139
56. Huang, L. Y., Halder, S., and Agbandje-McKenna, M. (2014). P.rvovirus glycan interactions. Curr. Opin. Virol. 7C, 108-118. doi: 10.1016/j.coviro.2014.05.007
57. Iliff, J. J, Wang, M., Liao, Y., P.ogg, B. A., P.ng, W., Gundersen, G. A., et al. (2012). A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 4:147-111. doi: 10.1126/scitranslmed.3003748
58. Irwin, D. J., Lee, V. M., and Trojanowski, J. Q. (2013). P.rkinson’s disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat. Rev. Neurosci. 14, 626-636. doi: 10.1038/nrn3549
59. Iwata, N., Sekiguchi, M., Hattori, Y., Takahashi, A., Asai, M., Ji, B., et al. (2013). Global brain delivery of neprilysin gene by intravascular administration of AAV vector in mice. Sci. Rep. 3:1472. doi: 10.1038/srep01472
60. Jacques, S. J., Ahmed, Z., Forbes, A., Douglas, M. R., Vigenswara, V., Berry, M., et al. (2012). AAV8(gfp) preferentially targets large diameter dorsal root ganglion neurones after both intra-dorsal root ganglion and intrathecal injection. Mol. Cell. Neurosci. 49, 464-474. doi: 10.1016/j.mcn.2012.03.002
61. Jang, J. H., Koerber, J. T., Kim, J. S., Asuri, P., Vazin, T., Bartel, M., et al. (2011). An evolved adeno-associated viral variant enhances gene delivery and gene targeting in neural stem cells. Mol. Ther. 19, 667-675. doi: 10.1038/mt.2010.287
62. Kaludov, N., Brown, K. E., Walters, R. W., Zabner, J., and Chiorini, J. A. (2001). Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75, 6884-6893. doi: 10.1128/JVI.75.15.6884-6893.2001
63. Kawamoto, S., Shi, Q., Nitta, Y., Miyazaki, J., and Allen, M. D. (2005). Widespread and early myocardial gene expression by adeno-associated virus vector type 6 with a beta-actin hybrid promoter. Mol. Ther. 11, 980-985. doi: 10.1016/j.ymthe.2005.02.009
64. Kells, A. P., Hadaczek, P., Yin, D., Bringas, J., Varenika, V., Forsayeth, J., et al. (2009). Efficient gene therapy-based method for the delivery of therapeutics to primate cortex. P.oc. Natl. Acad. Sci. U.S.A. 106, 2407-2411. doi: 10.1073/pnas.0810682106
65. Koh, L., Zakharov, A., and Johnston, M. (2005). Integration of the subarachnoid space and lymphatics: is it time to embrace a new concept of cerebrospinal fluid absorption? Cerebrospinal Fluid Res. 2:6. doi: 10.1186/1743-8454-2-6
66. Lehtinen, M. K., Bjornsson, C. S., Dymecki, S. M., Gilbertson, R. J., Holtzman, D. M., and Monuki, E. S. (2013). The choroid plexus and cerebrospinal fluid: emerging roles in development, disease, and therapy. J. Neurosci. 33, 17553-17559. doi: 10.1523/JNEUROSCI.3258-13.2013
67. Lentz, T. B., Gray, S. J., and Samulski, R. J. (2012). Viral vectors for gene delivery to the central nervous system. Neurobiol. Dis. 48, 179-188. doi: 10.1016/j.nbd.2011.09.014
68. Lin, D., Fantz, C. R., Levy, B., Rafi, M. A., Vogler, C., Wenger, D. A., et al. (2005). AAV2/5 vector expressing galactocerebrosidase ameliorates CNS disease in the murine model of globoid-cell leukodystrophy more efficiently than AAV2. Mol. Ther. 12, 422-430. doi: 10.1016/j.ymthe.2005.04.019
69. Liu, G., Martins, I. H., Chiorini, J. A., and Davidson, B. L. (2005a). Adeno-associated virus type 4 (AAV4) targets ependyma and astrocytes in the subventricular zone and RMS. Gene Ther. 12, 1503-1508. doi: 10.1038/sj.gt.3302554
70. Liu, G., Martins, I., Wemmie, J. A., Chiorini, J. A., and Davidson, B. L. (2005b). Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. J. Neurosci. 25, 9321-9327. doi: 10.1523/JNEUROSCI.2936-05.2005
71. Low, K., Aebischer, P., and Schneider, B. L. (2013). Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particles. Hum. Gene Ther. 24, 613-629. doi: 10.1089/hum.2012.174
72. Maguire, C. A., Gianni, D., Meijer, D. H., Shaket, L. A., Wakimoto, H., Rabkin, S. D., et al. (2010). Directed evolution of adeno-associated virus for glioma cell transduction. J. Neurooncol. 96, 337-347. doi: 10.1007/s11060-009-9972-7
73. Mandel, R. J., and Burger, C. (2004). Clinical trials in neurological disorders using AAV vectors: promises and challenges. Curr. Opin. Mol. Ther. 6, 482-490.
74. Masamizu, Y., Okada, T., Kawasaki, K., Ishibashi, H., Yuasa, S., Takeda, S., et al. (2011). Local and retrograde gene transfer into primate neuronal pathways via adeno-associated virus serotype 8 and 9. Neuroscience 193, 249-258. doi: 10.1016/j.neuroscience.2011.06.080
75. Mastakov, M. Y., Baer, K., Kotin, R. M., and During, M. J. (2002). Recombinant adeno-associated virus serotypes 2and 5-mediated gene transfer in the mammalian brain: quantitative analysis of heparin co-infusion. Mol. Ther. 5, 371-380. doi: 10.1006/mthe.2002.0564
76. McCarty, D. M., DiRosario, J., Gulaid, K., Muenzer, J., and Fu, H. (2009). Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MP. IIIB mice. Gene Ther. 16, 1340-1352. doi: 10.1038/gt.2009.85
77. McCarty, D. M., Young, S. M. Jr., and Samulski, R. J. (2004). Integration of adenoassociated virus (AAV) and recombinant AAV vectors. Annu. Rev. Genet. 38, 819-845. doi: 10.1146/annurev.genet.37.110801.143717
78. McCown, T. J., Xiao, X., Li, J., Breese, G. R., and Samulski, R. J. (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713, 99-107. doi: 10.1016/0006-8993(95) 01488-8
79. Nash, K., Chen, W., and Muzyczka, N. (2008). Complete in vitro reconstitution of adeno-associated virus DNA replication requires the minichromosome maintenance complex proteins. J. Virol. 82, 1458-1464. doi: 10.1128/JVI.01968-07
80. Nguyen, J. B., Sanchez-P.rnaute, R., Cunningham, J., and Bankiewicz, K. S. (2001). Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport 12, 1961-1964. doi: 10.1097/00001756-200107030-00037
81. Orr, H. T., and Zoghbi, H. Y. (2007). Trinucleotide repeat disorders. Annu. Rev. Neurosci. 30, 575-621. doi: 10.1146/annurev.neuro.29.051605.113042
82. Osakada, F., Mori, T., Cetin, A. H., Marshel, J. H., Virgen, B., and Callaway, E. M. (2011). New rabies virus variants for monitoring and manipulating activity and gene expression in defined neural circuits. Neuron 71, 617-631. doi: 10.1016/j.neuron.2011.07.005
83. P.dron, E., Bowman, V., Kaludov, N., Govindasamy, L., Levy, H., Nick, P., et al. (2005). Structure of adeno-associated virus type 4. J. Virol. 79, 5047-5058. doi: 10.1128/JVI.79.8.5047-5058.2005
84. P.ssini, M. A., and Wolfe, J. H. (2001). Widespread gene delivery and structurespecific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector. J. Virol. 75, 12382-12392. doi: 10.1128/JVI.75.24.12382-12392.2001
85. Rabinowitz, J. E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., et al. (2002). Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76, 791-801. doi: 10.1128/JVI.76.2.791-801.2002
86. Rafi, M. A., Rao, H. Z., Luzi, P., Curtis, M. T., and Wenger, D. A. (2012). Extended normal life after AAVrh10-mediated gene therapy in the mouse model of krabbe disease. Mol. Ther. 20, 2031-2042. doi: 10.1038/mt.2012.153
87. Rennels, M. L., Gregory, T. F., Blaumanis, O. R., Fujimoto, K., and Grady, P. A. (1985). Evidence for a "paravascular" fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space. Brain Res. 326, 47-63. doi: 10.1016/0006-8993(85)91383-6
88. Rosenberg, J. B., Sondhi, D., Rubin, D. G., Monette, S., Chen, A., Cram, S., et al. (2014). Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh.10 expressing the human arylsulfatase A cDNA to nonhuman primates. Hum. Gene Ther. Clin. Dev. doi: 10.1089/humc.2013.239 [Epub ahead of print].
89. Rothermel, M., Brunert, D., Zabawa, C., Diaz-Quesada, M., and Wachowiak, M. (2013). Transgene expression in target-defined neuron populations mediated by retrograde infection with adeno-associated viral vectors. J. Neurosci. 33, 15195-15206. doi: 10.1523/JNEUROSCI.1618-13.2013
90. Salegio, E. A., Samaranch, L., Kells, A. P., Mittermeyer, G., San Sebastian, W., Zhou, S., et al. (2013). Axonal transport of adeno-associated viral vectors is serotype-dependent. Gene Ther. 20, 348-352. doi: 10.1038/gt.2012.27
91. Samaranch, L., Salegio, E. A., San Sebastian, W., Kells, A. P., Bringas, J. R., Forsayeth, J., et al. (2013). Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum. Gene Ther. 24, 526-532. doi: 10.1089/hum.2013.005
92. Samaranch, L., Salegio, E. A., San Sebastian, W., Kells, A. P., Foust, K. D., Bringas, J. R., et al. (2012). Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum. Gene Ther. 23, 382-389. doi: 10.1089/hum.2011.200
93. San Sebastian, W., Samaranch, L., Heller, G., Kells, A. P., Bringas, J., P.virotto, P., et al. (2013). Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Ther. 20, 1178-1183. doi: 10.1038/gt.2013.48
94. Sawamoto, K., Wichterle, H., Gonzalez-P.rez, O., Cholfin, J. A., Yamada, M., Spassky, N., et al. (2006). New neurons follow the flow of cerebrospinal fluid in the adult brain. Science 311, 629-632. doi: 10.1126/science.1119133
95. Shen, F., Kuo, R., Milon-Camus, M., Han, Z., Jiang, L., Young, W. L., et al. (2013). Intravenous delivery of adeno-associated viral vector serotype 9 mediates effective gene expression in ischemic stroke lesion and brain angiogenic foci. Stroke 44, 252-254. doi: 10.1161/STROKEAHA.112.662965
96. Shen, S., Bryant, K. D., Brown, S. M., Randell, S. H., and Asokan, A. (2011). Terminal N-linked galactose is the primary receptor for adeno-associated virus 9. J. Biol. Chem. 286, 13532-13540. doi: 10.1074/jbc.M110.210922
97. Simonato, M., Bennett, J., Boulis, N. M., Castro, M. G., Fink, D. J., Goins, W. F., et al. (2013). P.ogress in gene therapy for neurological disorders. Nat. Rev. Neurol. 9, 277-291. doi: 10.1038/nrneurol.2013.56
98. Snyder, B. R., Gray, S. J., Quach, E. T., Huang, J. W., Leung, C. H., Samulski, R. J., et al. (2011). Comparison of adeno-associated viral vector serotypes for spinal cord and motor neuron gene delivery. Hum. Gene Ther. 22, 1129-1135. doi: 10.1089/hum.2011.008
99. Sondhi, D., Hackett, N. R., P.terson, D. A., Stratton, J., Baad, M., Travis, K. M., et al. (2007). Enhanced survival of the LINCL mouse following CLN2 gene transfer using the rh.10 rhesus macaque-derived adeno-associated virus vector. Mol. Ther. 15, 481-491. doi: 10.1038/sj.mt.6300049
100. Summerford, C., and Samulski, R. J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445.
101. Taylor, M. P., Kobiler, O., and Enquist, L. W. (2012). Alphaherpesvirus axon-to-cell spread involves limited virion transmission. P.oc. Natl. Acad. Sci. U.S.A. 109, 17046-17051. doi: 10.1073/pnas.1212926109
102. Tenenbaum, L., Chtarto, A., Lehtonen, E., Velu, T., Brotchi, J., and Levivier, M. (2004). Recombinant AAV-mediated gene delivery to the central nervous system. J. Gene Med. 6(Suppl. 1), S212-S222. doi: 10.1002/jgm.506
103. Vandenberghe, L. H., Wilson, J. M., and Gao, G. (2009). Tailoring the AAV vector capsid for gene therapy. Gene Ther. 16, 311-319. doi: 10.1038/gt.2008.170
104. Vulchanova, L., Schuster, D. J., Belur, L. R., Riedl, M. S., P.detz-P.dersen, K. M., Kitto, K. F., et al. (2010). Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture. Mol. P.in 6:31. doi: 10.1186/1744-8069-6-31
105. Walters, R. W., Yi, S. M., Keshavjee, S., Brown, K. E., Welsh, M. J., Chiorini, J. A., et al. (2001). Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276, 20610-20616. doi: 10.1074/jbc.M101559200
106. Wenger, D. A., Coppola, S., and Liu, S. L. (2002). Lysosomal storage disorders: diagnostic dilemmas and prospects for therapy. Genet. Med. 4, 412-419. doi: 10.1097/00125817-200211000-00003
107. Wickersham, I. R., Finke, S., Conzelmann, K. K., and Callaway, E. M. (2007). Retrograde neuronal tracing with a deletion-mutant rabies virus. Nat. Methods 4, 47-49. doi: 10.1038/nmeth999
108. Wu, Z., Asokan, A., Grieger, J. C., Govindasamy, L., Agbandje-McKenna, M., and Samulski, R. J. (2006a). Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes. J. Virol. 80, 11393-11397. doi: 10.1128/JVI.01288-06
109. Wu, Z., Miller, E., Agbandje-McKenna, M., and Samulski, R. J. (2006b). Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80, 9093-9103. doi: 10.1128/JVI.00895-06
110. Xiao, X., Li, J., and Samulski, R. J. (1998). P.oduction of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232.
111. Xiao, X., Xiao, W., Li, J., and Samulski, R. J. (1997). A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle. J. Virol. 71, 941-948.
112. Yamashita, T., Chai, H. L., Teramoto, S., Tsuji, S., Shimazaki, K., Muramatsu, S., et al. (2013). Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons. EMBO Mol. Med. 5, 1710-1719. doi: 10.1002/emmm.201302935
113. Yang, B., Li, S., Wang, H., Guo, Y., Gessler, D. J., Cao, C., et al. (2014). Global CNS transduction of adult mice by intravenously delivered rAAVrh.8 and rAAVrh.10 and nonhuman primates by rAAVrh.10. Mol. Ther. 22, 1299-1309. doi: 10.1038/mt.2014.68
114. Zhang, H., Yang, B., Mu, X., Ahmed, S. S., Su, Q., He, R., et al. (2011). Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system. Mol. Ther. 19, 1440-1448. doi: 10.1038/mt.2011.98